CorMedix (CRMD) Cash from Operations (2010 - 2025)

CorMedix has disclosed Cash from Operations across 15 years of filings, most recently posting 94461181.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 94461181.0, up 1782.34% year-over-year; the trailing twelve-month figure through Dec 2025 was 175046000.0 (up 445.84% YoY), and the FY2025 annual result was 175046000.0, up 445.84% from the prior year.
• Cash from Operations came in at 94461181.0 for Q4 2025 at CorMedix, up from 30856502.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 94461181.0 in Q4 2025 to a low of 17310294.0 in Q1 2024.
• The 5-year median for Cash from Operations is 6075137.5 (2022), against an average of 2025478.25.
• Across the five-year window, Cash from Operations sank 309.81% in 2021 and surged 1782.34% in 2025, its largest moves.
• CorMedix's Cash from Operations stood at 5869360.0 in 2021, then decreased by 4.86% to 6154839.0 in 2022, then tumbled by 74.59% to 10745694.0 in 2023, then surged by 47.75% to 5614883.0 in 2024, then soared by 1782.34% to 94461181.0 in 2025.
• The last three Cash from Operations figures came in at 94461181.0 (Q4 2025), 30856502.0 (Q3 2025), and 29991814.0 (Q2 2025), per Business Quant data.